Skin Diseases, Genetic
Diseases of the skin with a genetic component, usually the result of various inborn errors of metabolism.
Subtype terms (32)
More specific conditions that are subtypes of Skin Diseases, Genetic in the MeSH hierarchy.
- Albinism
6 drugs (4 approved, 2 experimental)
- Cutis Laxa
2 drugs experimental
- Darier Disease
1 drug approved
- Dermatitis, Atopic
437 drugs (133 approved, 304 experimental)
- Dyskeratosis Congenita
21 drugs (17 approved, 4 experimental)
- Ectodermal Dysplasia
- Ehlers-Danlos Syndrome
10 drugs (7 approved, 3 experimental)
- Epidermolysis Bullosa
54 drugs (26 approved, 28 experimental)
- Erythrokeratodermia Variabilis
- Hereditary Autoinflammatory Diseases
5 drugs (3 approved, 2 experimental)
- Hyaline Fibromatosis Syndrome
- Ichthyosiform Erythroderma, Congenital
1 drug approved
- Ichthyosis Bullosa of Siemens
- Ichthyosis Vulgaris
2 drugs experimental
- Ichthyosis, X-Linked
- Incontinentia Pigmenti
- Keratoderma, Palmoplantar
4 drugs (2 approved, 2 experimental)
- Leukokeratosis, Hereditary Mucosal
- Lipoid Proteinosis of Urbach and Wiethe
- Monilethrix
- Muir-Torre Syndrome
- Netherton Syndrome
11 drugs (4 approved, 7 experimental)
- Pemphigus, Benign Familial
2 drugs approved
- Porokeratosis
- Porphyria, Erythropoietic
- Porphyrias, Hepatic
1 drug approved
- Prolidase Deficiency
- Pseudoxanthoma Elasticum
8 drugs (4 approved, 4 experimental)
- Rothmund-Thomson Syndrome
- Sjogren-Larsson Syndrome
2 drugs experimental
- Trichothiodystrophy Syndromes
- Xeroderma Pigmentosum
3 drugs approved
Drugs by status
Phase 3 trials (3)
Phase 2 trials (5)
Organizations
Organization Involved with Phase 3 Indications (4)
Organization Involved with Phase 2 Indications (3)